Plasminogen activator inhibitor-1

被引:65
作者
Gils, A [1 ]
Declerck, PJ [1 ]
机构
[1] Catholic Univ Louvain, Fac Pharmaceut Sci, Lab Pharmaceut Biol & Phytopharmacol, B-3000 Louvain, Belgium
关键词
PAI-1; serpin; fibrinolysis; thrombosis;
D O I
10.2174/0929867043364595
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasminogen activator inhibitor-1 (PAI-1) is an important component of the plasminogen/plasmin system as it is the main inhibitor of tissue-type and urokinase-type plasminogen activator. Consequently, PAI-1 plays an important role in cardiovascular diseases (mainly through inhibition of t-PA) and in cell migration and tumor development (mainly through inhibition of u-PA). As a member of the serpin superfamily, PAI-1 shares important structural properties with other serpins. However, PAI-1 also exhibits unique conformational and functional properties. The current paper provides an overview of the knowledge on PAI-1 gathered since its discovery two decades ago. We are discussing (a) its structural properties and their subsequent association with the functional properties, (b) its role in a wide variety of (patho)physiological processes and (c) a number of strategies to interfere with its functional properties eventually aiming at pharmacological modulation of this risk factor.
引用
收藏
页码:2323 / 2334
页数:12
相关论文
共 200 条
[21]   The distal hinge of the reactive site loop and its proximity - A target to modulate plasminogen activator inhibitor-1 activity [J].
Bijnens, AP ;
Gils, A ;
Stassen, JM ;
Komissarov, AA ;
Knockaert, I ;
Brouwers, E ;
Shore, JD ;
Declerck, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) :44912-44918
[22]   Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator [J].
Bjorquist, P ;
Ehnebom, J ;
Inghardt, T ;
Deinum, J .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1341 (01) :87-98
[23]   Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis [J].
Björquist, P ;
Ehnebom, J ;
Inghardt, T ;
Hansson, L ;
Lindberg, M ;
Linschoten, M ;
Strömqvist, M ;
Deinum, J .
BIOCHEMISTRY, 1998, 37 (05) :1227-1234
[24]   MODULATORS OF COAGULATION - A CRITICAL-APPRAISAL OF THEIR ROLE IN SEPSIS [J].
BONE, RC .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (07) :1381-1389
[25]   PLASMINOGEN-ACTIVATOR INHIBITOR FROM HUMAN-ENDOTHELIAL CELLS - PURIFICATION AND PARTIAL CHARACTERIZATION [J].
BOOTH, NA ;
MACGREGOR, IR ;
HUNTER, NR ;
BENNETT, B .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 165 (03) :595-600
[26]   PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN PLASMA AND PLATELETS [J].
BOOTH, NA ;
SIMPSON, AJ ;
CROLL, A ;
BENNETT, B ;
MACGREGOR, IR .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 70 (03) :327-333
[27]   LYSIS OF PLATELET-RICH THROMBI - THE ROLE OF PAI-1 [J].
BOOTH, NA ;
ROBBIE, LA ;
CROLL, AM ;
BENNETT, B .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 667 :70-80
[28]   Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis [J].
Brodsky, S ;
Chen, J ;
Lee, A ;
Akassoglou, K ;
Norman, J ;
Goligorsky, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (04) :H1784-H1792
[29]   Inhibition of plasminogen activator inhibitor-1 activity by two diketopiperazines, XR330 and XR334 produced by Streptomyces sp. [J].
Bryans, J ;
Charlton, P ;
ChicarelliRobinson, I ;
Collins, M ;
Faint, R ;
Latham, C ;
Shaw, I ;
Trew, S .
JOURNAL OF ANTIBIOTICS, 1996, 49 (10) :1014-1021
[30]   PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION [J].
CARMELIET, P ;
KIECKENS, L ;
SCHOONJANS, L ;
REAM, B ;
VANNUFFELEN, A ;
PRENDERGAST, G ;
COLE, M ;
BRONSON, R ;
COLLEN, D ;
MULLIGAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2746-2755